Corrigendum

Hotter B, Padberg I, Liebenau A, et al. Identifying unmet needs in long-term stroke care using in-depth assessment and the Post-Stroke Checklist – The Managing Aftercare for Stroke (MAS-I) study. Eur Stroke J 2018; 3(3): 237–245.

In this article Tables 1, 3 and 4 are incorrect. The correct tables are printed below:

Table 1.

Domains explored, according assessments and cut-off measures used to define significant deficit.

Domains	Assessment	Cut-Offs used	Reference
Self reported need	Post Stroke Checklist (PSC)	>0 points	38
Quality of life	EuroQoL (EQ-5D-3L)	–	40
Overall function	Modified Rankin Scale (mRS)Barthel-Index (BI)	–	41,42
Spasticity	Modified Ashworth Scale (mAS) in REPAS system	mAS 3 or 4 in at least 1 joint	36,37
Post Stroke Pain	PainDetect	>12 points	43
Aphasia	Partial Aachen Aphasia Test (Token Test)	>3 points	44
Cognitive deficits	Montreal Cognitive Assessment	<26 points	45
Depression	Hamilton Depression Scale (HAMD-17)	>8 points	46
Secondary Prevention	Morisky Medication Adherence scale (MMAS)	>2 points	47,50,51
Social needs	Nikolaus score for evaluation of social conditions (SoS)	<17 points	48
Caregiver burden	Burden Scale for Family Caregivers	>9 points	49

Use of the ©MMAS is protected by US copyright laws. Permission for use is required. A license agreement is available from: Donald E. Morisky, ScD, ScM, MSPH, Professor, Department of Community Health Sciences, VCLA School ofPublic Health, 650 Charles E. Young Drive South, Los Angeles, CA 90095-1772.

Table 3.

Clinical and patient-reported outcome measures at assessment and recommendations by stroke specialist.

	Total
n (%)	57 (100)
Current mRS	2 (1–3)
Delta mRS	0 (0–1)
Current BI	95 (80–100)
PROM scales
EQoL-5D IV	0.81 (0.70–1.00)
EQoL-5D VAS	70 (50–85)
Any need in PSC (score > 0)	54 (95)
Affected according to validated scales, n (%)
Significant spasticity (mAS)	20 (35)
Neuropathic pain (PD)	1 (2)
Social needs (Nikolaus)	10 (18)
Morisky Medication Adherence scale (MMAS)	8 (14)
Speech impairment (TT)	5 (9)
Cognitive deficits (MoCA)	34 (61)
Depression (HD17)	11 (20)
Caregiver (BSFC)	6 (24)
Affected according to any of these scales	51 (90)
n deficits according to these scales, median (IQR)	2 (1–2)
Patient reported FU, n (%)
BP management	51 (91)
Cognition screening	26 (46)
Depression screening	21 (37)
Spasticity management	19 (58)
Fall management and prevention	21 (84)
Recovery of mobility	46 (92)
Recovery of walking	42 (88)
Recovery-assistive ULF	37 (84)
Recovery functional ULF	31 (69)
Family support available	48 (92)
Access further therapies	46 (92)
Social needs counselling	31 (60)
Stop smoking assistance	7 (54)
Management of malnutrition	7 (44)
Stroke specialist recommendations, n (%)
Medical review	17 (30)
Change in medication	10 (18)
Rehabilitation	4 (7)
Outpatient therapy	27 (47)
Social worker intervention	19 (33)
n recommendations per patient, median (IQR)	1 (0.5–2)

FU: follow-up; ULF: upper limb function; BI: Barthel Index; EQoL-5D EuroQuol; mRS: modified Rankin Scale; BP: blood pressure; PROM: patient-reported outcome measure; IV: index value; VAS: Visual Analogue Scale; PSC: Post-Stroke Checklist; TT: token test; PD: PainDetect; HD17: Hamilton Depression Scale 17 Items; MoCA: Montreal Cognitive Assessment; mAS: modified Ashworth Scale, Nikolaus Social Situation score, MMAS Morisky Medication Adherence Scale; BSFC: Burden Scale for Family Caregivers.

Numbers given are presented as median (interquartile range (IQR)) if not specified otherwise.

Use of the ©MMAS is protected by US copyright laws. Permission for use is required. A license agreement is available from: Donald E. Morisky, ScD, ScM, MSPH, Professor, Department of Community Health Sciences, VCLA School ofPublic Health, 650 Charles E. Young Drive South, Los Angeles, CA 90095-1772.

Table 4.

Association of quality of life as measured by EuroQoL and clinical deficits as well as the sensitivities, specificities; negative and positive predictive values of the PSC to detect stroke-related health problems as measured by validated scales.

EuroQoL-5D	TT	PD	HD17	MoCA	mAS	Nikolaus	MMAS	BSFC
Index Value	0.926	0.405	0.131	0.121	0.008	0.017	0.723	0.067
VAS	0.288	0.173	0.092	0.289	0.051	<0.001	0.596	0.116
PSC item (clinical scale compared)				Sens	Spec	PPV	NPV	p
Spasticity (mAS)				0.55	0.64	0.46	0.72	0.260
Pain (PD)				1.00	0.33	0.11	1.00	1.000
Communication (TT)				0.40	0.79	0.15	0.93	0.319
Mood (HD17)				0.91	0.71	0.44	0.97	<0.001
Cognition (MoCA)				0.38	0.27	0.45	0.22	0.015
Life after Stroke (Nikolaus)				0.90	0.60	0.32	0.97	0.005
Family Relationship (BSFC)				0.50	0.95	0.75	0.86	0.031
Any PSC item (any need on clinical scale)				0.94	0	0.89	0	1.000

VAS: Visual Analogue Scale; TT: token test; PD: PainDetect; HD17: Hamilton Depression Scale 17 Items; MoCA: Montreal Cognitive Assessment; mAS: modified Ashworth Scale, Nikolaus Social Situation score, MMAS: Morisky Medication Adherence scale MMAS; BSFC: Burden Scale for Family Caregivers; PSC: Post-Stroke Checklist; Sec.: secondary; ADL: activities of daily living; Sens.: sensitivity; Spec.: specificity; PPV: positive predictive value; NPV: negative predictive value.

Numbers given are p values obtained by Fisher’s exact test unless otherwise specified. For the PROM PSC Items associations were calculated where there are corresponding scales in the clinical scales.

Use of the ©MMAS is protected by US copyright laws. Permission for use is required. A license agreement is available from: Donald E. Morisky, ScD, ScM, MSPH, Professor, Department of Community Health Sciences, VCLA School ofPublic Health, 650 Charles E. Young Drive South, Los Angeles, CA 90095-1772.

In this article, references 50 and 51 are missing. They are listed below:

50. Krousel-Wood MA, Islam T, Webber LS, et al. New Medication Adherence Scale Versus Pharmacy Fill Rates in Seniors With Hypertension. Am J Manag Care 2009; 15: 59–66.

51. Morisky DE and DiMatteo MR. Improving the measurement of self-reported medication nonadherence: Final response. J Clin Epidemio 2011; 64: 258–263.